miRNA-Mediated Regulation of Ferroptosis in Neurological Disorders: Mechanisms and Therapeutic Implications

Chenyu Wang1, Tingrui Luo1, Nanhao Zhou1

  • 1Health Science Center, Ningbo University, Ningbo 315211, China.

Insights

MicroRNAs (miRNAs) regulate ferroptosis, a cell death pathway causing neuronal injury in neurological disorders. Targeting these miRNA networks offers a promising neuroprotective therapy for conditions like stroke and Parkinson's disease.

Area of Science:

  • Neuroscience
  • Molecular Biology
  • Genetics

Background:

  • Ferroptosis, an iron-dependent cell death, drives neuronal injury in diverse neurological disorders.
  • MicroRNAs (miRNAs) are key post-transcriptional regulators influencing ferroptosis pathways.
  • Dysregulation of miRNA-mediated ferroptosis contributes to neurological disease pathology.

Purpose of the Study:

  • To review current understanding of miRNA-mediated ferroptosis in neurological disorders.
  • To explore the role of miRNAs in ferroptosis across various neurological conditions.
  • To highlight therapeutic strategies targeting miRNA-ferroptosis interactions.

Main Methods:

  • Literature review synthesizing research on ferroptosis and miRNAs in neurological diseases.
  • Analysis of core molecular pathways of ferroptosis: antioxidant defense, lipid peroxidation, iron metabolism.
  • Integration of evidence from stroke, epilepsy, Parkinson's, Alzheimer's, and other neurological conditions.

Main Results:

  • miRNA regulatory networks significantly modulate ferroptotic vulnerability in neurological disorders.
  • Disease-specific miRNA axes dictate pathological consequences of ferroptosis.
  • Exosome-based strategies targeting miRNA networks show preclinical neuroprotection.

Conclusions:

  • miRNA-mediated ferroptosis is a critical mechanistic framework in neurological disorders.
  • Targeting ferroptosis-related miRNA networks presents a promising therapeutic avenue.
  • Further research into miRNA-ferroptosis interactions could yield novel treatments for neurodegeneration.